Headline News

 

Gilead expands access plans for investigational Ebola antiviral obeldesivir

Posted on November 18, 2026

Thermo Fisher launches Gibco VaxEvo medium for adenovirus vaccine production

Posted on November 18, 2026

KarXT shows preliminary symptom improvements in Phase III Alzheimer’s psychosis studies

Posted on November 18, 2026

FDA grants accelerated approval to Nelkarmi for previously treated ALK-positive lung cancer

Posted on November 18, 2026

Johnson & Johnson to acquire Ollin Biosciences for $2.2bn to expand ophthalmology pipeline

Posted on November 17, 2026

FDA clears expanded ENT indication for Johnson & Johnson’s HARMONIC 1100 Shears

Posted on November 17, 2026

FDA approves Klygefa for adults with generalised myasthenia gravis

Posted on November 17, 2026

Kyverna completes BLA submission for miv-cel in stiff person syndrome

Posted on November 15, 2026

FDA rejects ivonescimab lung cancer application after HARMONi overall survival miss

Posted on November 15, 2026

Andelyn partners with Celliaz to manufacture AAV gene therapy for retinitis pigmentosa

Posted on November 14, 2026

CHMP recommends Gazyva/Gazyvaro for systemic lupus erythematosus

Posted on November 14, 2026

Baloncibart reduces orthostatic heart rate and symptoms in Phase II POTS study

Posted on November 14, 2026

Abbott launches Panbio COVID-19 and flu self-test across Canada

Posted on November 13, 2026

CAPLYTA shows rapid improvement in bipolar mania in second pivotal Phase III study

Posted on November 13, 2026

Taltz and Zepbound combination maintains improved psoriatic arthritis outcomes at one year

Posted on November 11, 2026